[Individualized anticancer therapies: which regulatory guidelines?]

Bull Cancer. 2008 Oct;95(10):985-8. doi: 10.1684/bdc.2008.0733.
[Article in French]

Abstract

In this review, we will summarize the guidelines on the evaluation of anticancer medicinal products in man and definitions for genomic biomarkers (FDA validated), pharmacogenomics, pharmacogenetics, genomic data and sample coding categories.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Tumor / metabolism
  • Clinical Trials as Topic
  • Genetic Markers
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / genetics
  • Neoplasms / metabolism
  • Practice Guidelines as Topic

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Genetic Markers